The U.S. Department of Commerce, International Trade Administration, U.S. and Foreign Commercial Service is organizing a Trade Mission to explore opportunities in the Life Sciences in Melbourne, Australia, October 29- November 2, 2012.
In Melbourne, the U.S. mission members will be briefed by International Trade Administration CS staff, and other key U.S. government officials. Senior American Consulate officials will host a networking event for the group with Australian biotech and life science industry organizations and multipliers. During the mission, U.S. participants will benefit from attending the AusBiotech National Conference, customized one-on-one matchmaking with potential partners using the biopartnering.com platform, an efficient and easy to use personalized intelligent scheduling internet platform that facilitates scheduling appointments to connect with key people. And, receive a market briefing by the International Trade Administration Commercial Specialist for the biotech life science sector at the American Consulate, and networking activities. A site visit to Australia’s top biotech company and/or leading research institution will be offered.
Australia's US$11.39 billion pharmaceutical market is among the five largest in the Asia-Pacific region. Australia also has the region's second highest annual spending on medicine, after Japan. Much of this spending is on patented drugs, which account for 67% of the total pharmaceutical expenditure. Australia remains attractive to pharmaceutical firms -- per-capita healthcare spending is high (US$5,077) and the regulatory regime is comparable to those in other developed countries.
If you have any questions regarding this trade mission, please contact Gabriela Zelaya at 408-535-2757, ext. 107 or Gabriela.Zelaya@trade.gov or Aileen Nandi at 408-535-2757, ext. 102 or Aileen.Nandi@trade.gov. To apply for this mission, please download and complete the mission application and send via email to Gabriela.Zelaya@trade.gov. The application deadline is July 15, 2012.